Pacira BioSciences (PCRX) Exchange Rate Effect (2025 - 2026)

Pacira BioSciences (PCRX) posted quarterly Exchange Rate Effect of $38000.0 for Q1 2026, up 109.18% quarter-over-quarter from -$414000.0 in Q4 2025.

Pacira BioSciences (PCRX) Exchange Rate Effect (2025 - 2026) Analysis & Trends

Pacira BioSciences' Exchange Rate Effect history runs 2 years deep, the most recent figure standing at $38000.0 for Q1 2026.

In Q1 2026, Exchange Rate Effect changed N/A year-over-year to $38000.0; the TTM figure through Mar 2026 stood at -$39000.0 (changed N/A YoY), while the FY2025 annual figure was -$77000.0, changed N/A from the prior year.
Exchange Rate Effect for Q1 2026 stood at $38000.0, up from -$414000.0 in the prior quarter.
The five-year high for Exchange Rate Effect was $204000.0 in Q2 2025, with the low at -$414000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Exchange Rate Effect (Qtr)
1	Haleon	44.27 Bn	43.31 Bn	-	-
2	Teva Pharmaceutical Industries	43.64 Bn	39.99 Bn	2.15 Bn	-5.00 Mn
3	Zoetis	32.26 Bn	30.58 Bn	1.05 Bn	-7.00 Mn
4	Takeda Pharmaceutical	28.68 Bn	22.88 Bn	5.10 Bn	39.87 Mn
5	United Therapeutics	22.29 Bn	19.62 Bn	683.80 Mn	-
6	Viatris	18.86 Bn	17.98 Bn	1.46 Bn	-3.30 Mn
7	Neurocrine Biosciences	15.50 Bn	15.11 Bn	935.80 Mn	-
8	Elanco Animal Health	11.96 Bn	11.43 Bn	798.00 Mn	9.00 Mn
9	Dr Reddys Laboratories	10.10 Bn	9.94 Bn	-	-
10	Pacira BioSciences	947.88 Mn	696.85 Mn	148.24 Mn	-

Download Data